WASHINGTON, PARIS, and LONDON, June 11, 2018 /PRNewswire/ --
Tomorrow is a first-of-its-kind disease awareness event, the First International NASH Day, paving the way for a better care for millions of NASH patients in the future. This ground breaking event aims at raising awareness about a silent killer called NASH, thanks to an open and inclusive collaboration at a global level.
(Logo: https://mma.prnewswire.com/media/658690/International_NASH_DAY_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/658691/NASH_Education_Program_Logo.jpg )
The Forum for Collaborative Research is proud to support the first International NASH Day taking place tomorrow, June 12, 2018. This is a groundbreaking event organized by the NASH Education Program™ and its benefactors and supporters around the world. Over 20 international organizations have joined the coalition, and 150 key opinion leaders in the field have signed onto a global Call-to-Action. Veronica Miller, PhD, Executive Director of the Forum for Collaborative Research reflected on the importance of the 1st International NASH Day, noting, "The health and socio-economic burden of NASH will seriously impact health systems and productivity. NASH is insidious by nature, and many will be diagnosed too late. Even before end stage liver disease, NASH impacts metabolic and cardiovascular health. Increased awareness at patient, community and medical level is key to turning the tide on this public health emergency".
Symbolic launch of the 1st International NASH Day
The open and inclusive collaboration behind the First International NASH Day has been materialized by the call to action sent to the world on June 5, 2018 by 150 experts in liver and metabolic diseases. Most continents are represented.
It was a year ago in Europe that this groundbreaking initiative took shape thanks to a new impetus given by stakeholders specialized in NASH, liver and metabolic diseases. Since then, the heart of the global set-up remains European, with a pivotal role in supervising and coordinating the event.
Latin America has played a pivotal role in promoting the initiative across essential countries with populations particularly exposed to the risk of NASH, and has managed to create strong dynamics in the region.
In Asia, Singapore and Hong-Kong have taken some early steps to be part of the dynamics paving the way for a stronger involvement in 2019.
The United States have for many years been exposed to the threat represented by NASH, and for this first edition will host the symbolic launch of the International NASH Day:
Official ribbon cutting ceremony at 11:30am on Monday 11, 2018
On the U.S. Capitol hill, Washington DC
By: Ms. Pascaline Clerc (US campaign manager and US spokesperson - The NASH Education Program™), Ms. Donna Cryer (CEO - Global Liver Institute), Dr. Katherine Greene (Senior Research Associate - Liver Forum), Ben Goodman (NAFLD patient and son of a NASH patient, and staff assistant for a member of the U.S. House of Representatives), and Pr. Stephen A. Harrison (MD, PhD, Medical Director of Pinnacle Clinical Research, San Antonio, Texas; Visiting Professor of Hepatology at the Radcliffe Department of Medicine, University of Oxford; and member of the scientific committee of The NASH Education Program™).
A NASH-specific Congressional Briefing to Hill staffers will take place on the same day, demonstrating the recognition that NASH is a real threat to millions of people in the United States and beyond.
Online WebTV program
The program will be made available on https://www.international-nash-day.com
Program of on-site activities in 25+ cities across the globe
All details about official activities can be found on the official website of the event:
https://www.international-nash-day.com/take-action/join-an-activity
Note that while most activities take place on June 12, several events have also been organized a few days ahead of the 1st International NASH Day. The campaign will also continue after June 12.
Special thanks
Key opinion leaders from several countries across the globe are involved in the preparation of several local conferences, in collaboration with The NASH Education Program™. We want to commend specifically:
As a reminder official hashtags are #NASHday #MacLiver
NASH, or nonalcoholic steatohepatitis, is a metabolic disease characterized by the accumulation of fat in the liver, along with inflammation and the degeneration of liver cells. The disease is associated with long-term risk of progression into diminished liver functionality, leading to non-alcoholic cirrhosis, liver insufficiency and possibly even liver cancer. It also is associated with an increased risk of cardiovascular diseases which represent the leading cause of mortality for NASH patients. The rise of NASH is connected to type 2 diabetes and obesity epidemics that are growing globally.
About The NASH Education Program™
The non-profit NASH Education Program defines and drives initiatives in collaboration with an independent scientific committee composed of four international key opinion leaders in the hepatic and metabolic disease ecosystems in the U.S. and Europe. To learn more, visit http://www.the-nash-education-program.com.
Contact The NASH Education Program™ [email protected] Pascaline Clerc - U.S. Campaign Manager | [email protected] Press Relations For the EU: Ulysse Communication | Bruno Arabian | [email protected] | +33 687884726 For the US: SuSiglo Media | Maritza Puello | [email protected] | +1-917-886-3495
SOURCE The NASH Education Program
Advertisement
Tomorrow is a first-of-its-kind disease awareness event, the First International NASH Day, paving the way for a better care for millions of NASH patients in the future. This ground breaking event aims at raising awareness about a silent killer called NASH, thanks to an open and inclusive collaboration at a global level.
Advertisement
(Logo: https://mma.prnewswire.com/media/658690/International_NASH_DAY_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/658691/NASH_Education_Program_Logo.jpg )
- The NASH Education Program™ is proud to announce today that the Forum for Collaborative Research has endorsed the First International NASH Day and is now part of the large coalition of stakeholders involved in raising NASH awareness
- The NASH Education Program™ also discloses today the detailed program of this very special day for all patients as well as for the medical community caring for them
- Symbolic launch of the 1st International NASH Day will take place today in Washington DC (USA), on the occasion of a NASH-specific Congressional Briefing to Hill staffers
The Forum for Collaborative Research is proud to support the first International NASH Day taking place tomorrow, June 12, 2018. This is a groundbreaking event organized by the NASH Education Program™ and its benefactors and supporters around the world. Over 20 international organizations have joined the coalition, and 150 key opinion leaders in the field have signed onto a global Call-to-Action. Veronica Miller, PhD, Executive Director of the Forum for Collaborative Research reflected on the importance of the 1st International NASH Day, noting, "The health and socio-economic burden of NASH will seriously impact health systems and productivity. NASH is insidious by nature, and many will be diagnosed too late. Even before end stage liver disease, NASH impacts metabolic and cardiovascular health. Increased awareness at patient, community and medical level is key to turning the tide on this public health emergency".
Symbolic launch of the 1st International NASH Day
The open and inclusive collaboration behind the First International NASH Day has been materialized by the call to action sent to the world on June 5, 2018 by 150 experts in liver and metabolic diseases. Most continents are represented.
It was a year ago in Europe that this groundbreaking initiative took shape thanks to a new impetus given by stakeholders specialized in NASH, liver and metabolic diseases. Since then, the heart of the global set-up remains European, with a pivotal role in supervising and coordinating the event.
Latin America has played a pivotal role in promoting the initiative across essential countries with populations particularly exposed to the risk of NASH, and has managed to create strong dynamics in the region.
In Asia, Singapore and Hong-Kong have taken some early steps to be part of the dynamics paving the way for a stronger involvement in 2019.
The United States have for many years been exposed to the threat represented by NASH, and for this first edition will host the symbolic launch of the International NASH Day:
Official ribbon cutting ceremony at 11:30am on Monday 11, 2018
On the U.S. Capitol hill, Washington DC
By: Ms. Pascaline Clerc (US campaign manager and US spokesperson - The NASH Education Program™), Ms. Donna Cryer (CEO - Global Liver Institute), Dr. Katherine Greene (Senior Research Associate - Liver Forum), Ben Goodman (NAFLD patient and son of a NASH patient, and staff assistant for a member of the U.S. House of Representatives), and Pr. Stephen A. Harrison (MD, PhD, Medical Director of Pinnacle Clinical Research, San Antonio, Texas; Visiting Professor of Hepatology at the Radcliffe Department of Medicine, University of Oxford; and member of the scientific committee of The NASH Education Program™).
A NASH-specific Congressional Briefing to Hill staffers will take place on the same day, demonstrating the recognition that NASH is a real threat to millions of people in the United States and beyond.
Online WebTV program
The program will be made available on https://www.international-nash-day.com
- At 00:00 ET (UTC -05:00) on Tuesday, June 12, 2018
- At 06:00 CET (UTC +01:00) on Tuesday, June 12, 2018
- NASH (1/7): What is it?
- Speakers: Pr Stephen Harrison, Pr Sven Francque
- NASH (2/7): How common is it?
- Speakers: Pr Mary Rinella, Pr Marco Arrese, Pr Joel Lavine
- NASH (3/7): Who is at risk?
- Speakers: Pr Kenneth Cusi, Pr Jörn M. Schattenberg, Pr Elisabetta Bugianesi
- NASH (4/7): Getting Diagnosed
- Speakers: Pr Salvador Augustin, Pr Vlad Ratziu, Pr Jean-François Dufour, Pr Quentin Anstee
- NASH (5/7): Disease evolution and consequences
- Speakers: Pr Veronica Miller, Pr Vlad Ratziu
- NASH (6/7): Patient care and clinical management
- Speakers: Pr Laurent Castera, Pr Bertrand Cariou and colleagues, Tom Nealon
- NASH (7/7): What perspectives?
- Speakers: Pr Arun Sanyal, Donna Cryer, Pr Philip Newsome
Program of on-site activities in 25+ cities across the globe
All details about official activities can be found on the official website of the event:
https://www.international-nash-day.com/take-action/join-an-activity
- Patients and physicians conferences
- Street awareness happenings and others
- Free patients screenings
Note that while most activities take place on June 12, several events have also been organized a few days ahead of the 1st International NASH Day. The campaign will also continue after June 12.
Special thanks
Key opinion leaders from several countries across the globe are involved in the preparation of several local conferences, in collaboration with The NASH Education Program™. We want to commend specifically:
- The four members of the scientific committee of The NASH Education Program: Pr. Harrison, Pr. Francque, Pr. Cusi, Pr. Cariou.
- Organizers of special events: Dr. Manal Abdelmalek, Dr. William Alazawi, Pr. Francesco Angelico, Dr. Rodolphe Anty, Pr. Marco Arrese, Dr. Salvador Augustin, Dr. Stefan Bourgeois, Dr. Fernando Bril, Dr. Rotonya Carr, Pr. Kenneth Cusi, Pr. Laurent Castera, Dr. Yock Young Dan, Pr. Sven Francque, Dr. Adrian Gadano, Pr. Stephen Harrison, Dr. Anita Kholi, Pr. Laura Ladron de Guevara, Pr. Nicolas Lanthier, Pr. Rohit Loomba, Dr. Penelopi Manousou, Pr. Nahum Mendez-Sanchez, Pr. Veronica Miller, Pr. Manuel Romero-Gomez, Dr. Jörn Schattenberg, Dr. Brent Tetri, Dr. Emmanouil Tsochatzis, Dr. Julia Wattacheril, Dr. Allan Wolkoff, Dr. Yusuf Yilmaz
As a reminder official hashtags are #NASHday #MacLiver
- Official website
- Youtube
- American Liver Foundation (ALF)
- Association of Asian Pacific Community Health Organizations (AAPCHO)
- Barc
- British Liver Trust (BLT)
- Covance
- Cymabay Therapeutics
- Delpharm
- Diafir
- Echosens
- Enanta Pharmaceuticals
- Fatty Liver Foundation (FLF)
- Genfit
- Global Liver Institute (GLI)
- Health Unlocked
- Inventiva Pharma
- IQVIA
- Liver Forum - Forum for Collaborative Research
- National Hispanic Council on Aging (NHCOA)
- National Hispanic Medical Associations (NHMA)
- Parexel
- The Latin American Association for the Study of the Liver (ALEH)
- The Spanish Association for the Study of the Liver (AEEH)
- Histoindex (Singapore)
NASH, or nonalcoholic steatohepatitis, is a metabolic disease characterized by the accumulation of fat in the liver, along with inflammation and the degeneration of liver cells. The disease is associated with long-term risk of progression into diminished liver functionality, leading to non-alcoholic cirrhosis, liver insufficiency and possibly even liver cancer. It also is associated with an increased risk of cardiovascular diseases which represent the leading cause of mortality for NASH patients. The rise of NASH is connected to type 2 diabetes and obesity epidemics that are growing globally.
About The NASH Education Program™
The non-profit NASH Education Program defines and drives initiatives in collaboration with an independent scientific committee composed of four international key opinion leaders in the hepatic and metabolic disease ecosystems in the U.S. and Europe. To learn more, visit http://www.the-nash-education-program.com.
Contact The NASH Education Program™ [email protected] Pascaline Clerc - U.S. Campaign Manager | [email protected] Press Relations For the EU: Ulysse Communication | Bruno Arabian | [email protected] | +33 687884726 For the US: SuSiglo Media | Maritza Puello | [email protected] | +1-917-886-3495
SOURCE The NASH Education Program